Photodynamic therapy of age-related macular degeneration and atherosclerosis

E. Ben-Hur, H. Miller, B. Miller, I. Rosenthal

Research output: Contribution to journalConference articlepeer-review


In photodynamic therapy, a photosensitizing dye restrictively localized to certain sites in the biological milieu, is activated by visible light to selectively destroy the stained structure. Although primarily investigated for necroting malignant tumors, this approach also suggests potential in treating other pathological conditions such as age-related macular degeneration and atherosclerosis. Until recently, hematoporphyring derivative was practically the only dye investigated for photodynamic therapy. The use of phthalocyanine dyes is being explored as a superior alternative photosensitizer for treatment of these diseases.

Original languageEnglish
Pages (from-to)284-286
Number of pages3
JournalBerichte der Bunsengesellschaft/Physical Chemistry Chemical Physics
Issue number3
StatePublished - 1989
Externally publishedYes
EventDiscussion Meeting of The Deutsche Bunsen-Gesellschaft fuer Physikalische Chemie - Heildelberg, West Ger
Duration: 29 Aug 19881 Sep 1988

ASJC Scopus subject areas

  • General Chemical Engineering


Dive into the research topics of 'Photodynamic therapy of age-related macular degeneration and atherosclerosis'. Together they form a unique fingerprint.

Cite this